IRCCS Centro Neurolesi "Bonino Pulejo" - S.S. 113 C.da Casazza, Messina, Italy.
Medicine (Baltimore). 2021 Nov 12;100(45):e27747. doi: 10.1097/MD.0000000000027747.
Post-Stroke depression affects between 12% and 72% of patients who have suffered a stroke. The association between low serum levels of 25-hydroxyvitamin D (25(OH) D) and increased risk of depression is reported in both stroke and non-stroke patients. Similarly, high 25(OH) D levels might be associated with greater functional improvement during rehabilitation program.We wanted to investigate the effects of an intensive rehabilitation on poststroke outcomes. We wondered if the daily rehabilitation of motor and cognitive functions could also have an effect on mood and functional abilities in addition to or as an alternative to vitamin D supplementation.We conducted a 12-week, randomized trial, double blind, parallel, monocentric clinical trial of 40 patients undergoing intensive neuro-rehabilitation treatment at a specialized care facility for ischemic or hemorrhagic brain stroke. Participants were randomly assigned, in a 1:1 ratio, to 1 of 2 parallel groups: in the experimental group, 2000 IU/day of oral cholecalciferol was administered; in the control group patients were not taking vitamin D supplementation. Patients underwent a text evaluation to investigate psychological and motor outcomes.Significant intra-group difference in outcomes measures was found but not between control group and experimental group. In the vitamin D group, we highlighted significant differences between T0 and T1 in calcium (P < .001), vitamin D (P < .001), in Montgomery Aasberg Depression Rating Scale (P = .001), and in Functional Independent Measures (P < .001). In the health control group, we found a significant difference in calcium (P = .003), vitamin D (P < .001), Montgomery Aasberg Depression Rating Scale (P = 0.006), in general self-efficacy (P = .009), and in Functional Independent Measures (P < .001).Our results show that the beneficial effect on mood and functional recovery is mainly due to neurorehabilitation rather than vitamin D supplementation.
卒中后抑郁影响 12%至 72%的卒中患者。低血清 25-羟维生素 D(25(OH) D)水平与抑郁风险增加之间的关联在卒中患者和非卒中患者中均有报道。同样,高 25(OH) D 水平可能与康复计划期间更大的功能改善有关。我们想调查强化康复对卒中后结局的影响。我们想知道,除了维生素 D 补充剂之外,日常的运动和认知功能康复是否也会对情绪和功能能力产生影响,或者作为替代治疗。我们进行了一项为期 12 周的、随机的、双盲的、平行的、单中心临床试验,共有 40 名缺血性或出血性脑卒中患者在专门的脑卒中康复治疗中心接受强化神经康复治疗。参与者以 1:1 的比例随机分配到 2 个平行组中的 1 个:实验组每天口服 2000 IU 胆钙化醇;对照组患者未服用维生素 D 补充剂。患者接受文本评估以调查心理和运动结果。在组内发现了结果测量的显著差异,但在对照组和实验组之间没有发现差异。在维生素 D 组中,我们强调了 T0 和 T1 之间钙(P<0.001)、维生素 D(P<0.001)、蒙哥马利抑郁评定量表(P=0.001)和功能独立性测量(P<0.001)的显著差异。在健康对照组中,我们发现钙(P=0.003)、维生素 D(P<0.001)、蒙哥马利抑郁评定量表(P=0.006)、一般自我效能感(P=0.009)和功能独立性测量(P<0.001)有显著差异。我们的结果表明,对情绪和功能恢复的有益影响主要归因于神经康复,而不是维生素 D 补充剂。